GeminIQ

MRK

Merck & Co., Inc.
$144.91previous close on: 9/16/2026

Company Information

Company Name
Merck & Co., Inc.
CIK
CIK0000310158
Category
Large accelerated filer
Ticker: Exchange
MRK: NYSE
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2834
SIC Description
Pharmaceutical Preparations
Ticker
MRK

SEC filing data through

Insider Sentiment

Last purchase
2025-02-06
Last sale
2026-02-12
Shares purchased (TTM)
0
Shares sold (TTM)
374,872
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-03-31
Institutional shares owned
1,794,150,480
Shares outstanding
2,472,000,000
Ownership
72.58%
-0.21% Y/Y

Earnings Market Reaction

Filing date
2026-08-07
Price on filing date
—
1-month reaction
15.38%
3-month reaction
Pending
Drift continued4/11 (36%)
Faded / reversed7/11 (64%)
Export data

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value6,8495,32714,56518,1698,0078,62913,24214,59311,3045,5796,8418,605
Marketable Securities Current29237504561559944705040252168
Assets Current
Accounts Receivable Net Current12,56412,21011,77512,12011,84610,79010,27811,38111,64211,36610,34910,394
Assets Current36,67935,01543,51647,55737,06535,50338,78240,36138,20531,44532,16831,954
Inventory Net6,2076,4796,6586,4446,6016,1966,1096,2446,4696,5106,3586,131
Other Assets Current10,76710,62410,51810,7799,9969,2898,7068,1438,7407,9508,3686,656
Marketable Securities Noncurrent1,2221,1059561,1177746164635753572802521,306
Land--321---307---326-
Buildings And Improvements Gross--17,983---16,360---14,966-
Property Plant And Equipment Gross
Property Plant And Equipment Gross--47,230---42,934---41,317-
Machinery And Equipment Gross--19,760---18,283---17,763-
Construction In Progress Gross--9,166---7,984---8,262-
Property Plant And Equipment Net25,73725,43325,31625,63925,23624,79323,77923,44623,22123,04523,05122,526
Goodwill21,58221,58121,57921,58721,59121,68421,66821,69721,16121,18121,19721,183
Intangible Assets Net Excluding Goodwill24,97825,74526,68115,31315,19315,75816,37017,01016,98417,57218,01119,199
Other Assets Noncurrent19,60419,80618,81818,33317,66416,76816,04414,44312,70212,32611,99610,559
Assets129,802128,685136,866129,546117,523115,122117,106117,532112,630105,849106,675106,727
Liabilities And Stockholders Equity
Debt Current2,8252,4442,5891,4051,4341,3602,6493,1493,0713,0771,372887
Accounts Payable Current3,8273,8634,4044,1473,8923,7844,0793,5863,5193,5143,9223,509
Other Liabilities Current14,72514,54914,46816,18614,50212,77215,69416,53914,71214,10215,76614,840
Liabilities Current
Liabilities Current27,73126,94528,32728,62826,03725,17428,42029,58626,06025,09925,69423,094
Accrued Income Taxes Current4,2243,9464,7264,8484,1565,1813,9144,3302,7772,3982,6491,981
Dividends Payable Current2,1302,1432,1402,0422,0532,0772,0841,9821,9812,0081,9851,877
Long Term Debt Noncurrent51,08146,67346,75039,96933,96833,48434,46234,98234,71731,14233,68333,972
Deferred Income Tax Liabilities Net1,4331,4941,4391,3811,4271,4091,3878648769228711,018
Other Liabilities Noncurrent7,5737,6427,6887,6617,0316,6556,4657,5407,3298,2628,7927,343
Common Stock Value1,7881,7881,7881,7881,7881,7881,7881,7881,7881,7881,7881,788
Additional Paid In Capital Common Stock44,95045,17645,02944,83244,64444,81644,70444,53044,36244,59844,50944,358
Stockholders Equity
Stockholders Equity41,98445,87852,60651,90748,99348,33546,31344,50243,64840,42437,58141,300
Retained Earnings Accumulated Deficit63,26966,72173,07572,23168,47766,09763,06961,38460,18756,69753,89557,082
Accumulated Other Comprehensive Income Loss Net Of Tax-3,942-4,060-4,287-5,202-5,421-4,965-4,945-5,371-5,361-5,274-5,161-4,916
Stockholders Equity Before Treasury Stock106,065109,625115,605113,649109,488107,736104,616102,331100,97697,80995,03198,312
Treasury Stock Common Value64,13263,74762,99961,79960,49559,40158,30357,82957,39457,44557,45057,066
Minority Interest515356576765595866605454
Liabilities And Stockholders Equity129,802128,685136,866129,546117,523115,122117,106117,532112,630105,849106,675106,727
Allowance For Doubtful Accounts Receivable Current10810397939493897982808885
Inventory Noncurrent6,3816,1955,6815,4124,8824,5564,1933,9953,4563,4133,3483,151
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment22,72922,28821,91420,60520,25619,68019,15519,07218,96018,62018,26618,446
Common Stock Par Or Stated Value Per Share0.500.500.500.500.500.500.500.500.500.500.500.50
Common Stock Shares Authorized6,5006,5006,5006,5006,5006,5006,5006,5006,5006,5006,5006,500
Common Stock Shares Issued3,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,577
Treasury Stock Common Shares1,1081,1071,1021,0901,0741,0611,0491,0451,0411,0441,0451,042

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Merck & Co., Inc. (MRK) — SEC Financial Statements & Analysis

Merck & Co., Inc. (MRK) is a pharmaceutical preparations company, incorporated in NJ. Merck & Co., Inc. trades on NYSE as: MRK. Merck & Co., Inc. (MRK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, Merck & Co., Inc. carries a market cap of $317.39B, a P/E ratio of 99.84x, a P/B ratio of 7.56x, a P/S ratio of 4.77x, an enterprise value of $364.41B, and an EV/EBITDA multiple of 40.12x. On profitability, it posts a gross margin of 72.97%, an operating margin of 8.94%, a net margin of 4.78%, a Return on Equity (ROE) of 6.99%, a Return on Assets (ROA) of 2.57%, and a Return on Invested Capital (ROIC) of 3.78%. Per share, it reports EPS of $1.29, diluted EPS of $1.29, free cash flow per share of $6.50, and a dividend per share of $3.36. Over the trailing year, it posted revenue growth of 4.64% year-over-year, net income growth of -80.64% year-over-year, and EPS growth of -80.32% year-over-year. On the balance sheet, it maintains a current ratio of 1.32x, a quick ratio of 1.10x, working capital of $8.95B, a debt-to-equity ratio of 0.66x, a debt ratio of 0.21, free cash flow of $16.06B (TTM), and net debt of $47.02B. Figures sourced from SEC EDGAR.

Market Cap
$317.39B
P/E TTM
99.84x
EPS TTM
$1.29
P/B TTM
7.56x
ROE TTM
6.99%
ROA TTM
2.57%
Debt To Equity
0.66x
Free Cash Flow TTM
$16.06B
Net Revenue TTM Growth 1Y
4.64%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Merck & Co., Inc. in?

Merck & Co., Inc. (MRK) operates in the Pharmaceutical Preparations industry.

What exchange does MRK trade on?

Merck & Co., Inc. (MRK) trades on the NYSE.

Where is Merck & Co., Inc. incorporated?

Merck & Co., Inc. is incorporated in NJ.

When was Merck & Co., Inc. (MRK)'s most recent SEC filing?

Merck & Co., Inc. (MRK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.

What is MRK's market cap?

Merck & Co., Inc. (MRK) has a market capitalization of $317.39B as of 2026-06-30.

What is MRK's P/E ratio?

Merck & Co., Inc. (MRK)'s trailing twelve month P/E ratio is 99.84x as of 2026-06-30.

What is MRK's EPS (earnings per share)?

Merck & Co., Inc. (MRK)'s trailing twelve month EPS is $1.29 as of 2026-06-30.

What is MRK's ROE (return on equity)?

Merck & Co., Inc. (MRK)'s trailing twelve month Return on Equity (ROE) is 6.99% as of 2026-06-30.

What is MRK's ROA (return on assets)?

Merck & Co., Inc. (MRK)'s trailing twelve month Return on Assets (ROA) is 2.57% as of 2026-06-30.

What is MRK's ROIC (return on invested capital)?

Merck & Co., Inc. (MRK)'s trailing twelve month Return on Invested Capital (ROIC) is 3.78% as of 2026-06-30.

What is MRK's EV/EBITDA?

Merck & Co., Inc. (MRK)'s trailing twelve month EV/EBITDA is 40.12x as of 2026-06-30.

Wall Street's data.
Main Street's price.

Start 7-day free trial